Published in Int Arch Allergy Immunol on July 01, 1999
Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. Clin Exp Immunol (2009) 1.16
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis (2006) 0.98
Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol (2009) 0.84
Vasculitis treatment - new therapeutic approaches. Eur J Pediatr (2006) 0.82
Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve: a case report. J Med Case Rep (2012) 0.82
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin. Clin Rheumatol (2004) 0.80
Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatol Int (2004) 0.78
IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia. Clin Exp Immunol (2000) 0.76
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction? Ther Clin Risk Manag (2005) 0.76
Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa. Auto Immun Highlights (2013) 0.75
Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey. Clin Rheumatol (2005) 0.75
Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders. J Neurol (2006) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother (1995) 7.74
Prophage induction and cell division in E. coli. III. Mutations sfiA and sfiB restore division in tif and lon strains and permit the expression of mutator properties of tif. Mol Gen Genet (1975) 6.82
Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum (1997) 6.04
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol (2009) 5.33
Prophage induction and cell division in E. coli. I. Further characterization of the thermosensitive mutation tif-1 whose expression mimics the effect of UV irradiation. Mol Gen Genet (1972) 4.85
A neural basis for general intelligence. Science (2000) 4.49
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med (1975) 3.36
[Prophage induction and cell division in E. coli. II. Linked (recA, zab) and unlinked (lex) suppressors of tif-1-mediated induction and filamentation]. Mol Gen Genet (1972) 3.25
Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science (1998) 3.21
The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ (1968) 2.96
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ (1969) 2.77
Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Bull World Health Organ (1968) 2.71
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
OMFS: Gender imbalance? Br Dent J (2016) 2.56
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol (1995) 2.51
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Inducible sfi dependent division inhibition in Escherichia coli. Mol Gen Genet (1980) 2.50
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med (1982) 2.39
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (2010) 2.37
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29
A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer (2000) 2.27
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. Aliment Pharmacol Ther (2013) 2.26
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother (1995) 2.12
Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr (1999) 2.10
Indirect ultraviolet-reactivation of phage lambda. Proc Natl Acad Sci U S A (1974) 2.09
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia (1977) 2.08
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
The effect of magnesium sulphate infusion on the incidence and severity of emergence agitation in children undergoing adenotonsillectomy using sevoflurane anaesthesia. Anaesthesia (2013) 2.06
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Further characterization of sfiA and sfiB mutations in Escherichia coli. J Bacteriol (1980) 2.01
Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS) Clin Exp Rheumatol (1997) 2.01
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene (2011) 1.95
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet (1998) 1.95
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Estimating the true extent of cognitive decline in the old old. J Am Geriatr Soc (1999) 1.90
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
Transforming growth factor beta and the liver. Hepatology (2001) 1.83
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid (1999) 1.81
Transcriptional regulation of the mosquito vitellogenin gene via a blood meal-triggered cascade. Gene (2001) 1.81
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Do guidelines improve the process and outcomes of care in delirium? Age Ageing (2003) 1.74
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
Mechanism of repression of methionine biosynthesis in Escherichia coli. I. The role of methionine, s-adenosylmethionine, and methionyl-transfer ribonucleic acid in repression. Mol Gen Genet (1973) 1.73
Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J Clin Microbiol (2002) 1.72
Isolation and functional analysis of a human 70,000-dalton heat shock protein gene segment. Proc Natl Acad Sci U S A (1985) 1.70
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
A rapid procedure for DNA sequencing using transposon-promoted deletions in Escherichia coli. Gene (1985) 1.67
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest (2000) 1.66
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Unreamed interlocking nailing in open fractures of tibia. J Orthop Surg (Hong Kong) (2004) 1.60
Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol (2000) 1.59
Cognitive assessment in the elderly: a review of clinical methods. QJM (2007) 1.59
Assessment of the reproductive toxicity of a complex mixture of 25 groundwater contaminants in mice and rats. Fundam Appl Toxicol (1995) 1.58
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58
Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med (1995) 1.58
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55
Efficient transformation of the yellow fever mosquito Aedes aegypti using the piggyBac transposable element vector pBac[3xP3-EGFP afm]. Insect Biochem Mol Biol (2001) 1.55
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti. Proc Natl Acad Sci U S A (2000) 1.53
Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis. Aliment Pharmacol Ther (2012) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis (1994) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet (1998) 1.51
Breast clinic referrals: can mastalgia be managed in primary care? Ir J Med Sci (2014) 1.51
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49